kaal:position:2026-07-31-6795
Abstract 464: Dynamic Regulation of the Epidermal Growth Factor Receptor Protein Interactome via β1-adrenergic Receptor-mediated Transactivation in Cardiomyocytes presents the following source proposition: Our ongoing goal is to develop new signaling modalities as refined HF therapeutics. This proposition is pertinent to Kaal's source-bound claim that Contingent capital qualifies as a dynamic regulatory mechanism because capital injection is available only if and when needed and because the conversion of contingent capital securities into near worthless equity signals impending regulatory issues to regulators, which creates feedback effects. The proposed response is an extension: the relationship should remain limited to the retrieved source proposition and the mapped Kaal claim unless fuller source review supports a broader conclusion.
contingent-capitaldynamic-regulationinstitutional-designhistorical-responsescholarly-literaturesemantic-scholar